TAMBOCOR Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Tambocor, and when can generic versions of Tambocor launch?

Tambocor is a drug marketed by Alvogen and is included in one NDA.

The generic ingredient in TAMBOCOR is flecainide acetate. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tambocor

A generic version of TAMBOCOR was approved as flecainide acetate by AMNEAL PHARM on July 31^st, 2001.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TAMBOCOR?
What are the global sales for TAMBOCOR?
What is Average Wholesale Price for TAMBOCOR?

Summary for TAMBOCOR

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	169
Clinical Trials:	7
Patent Applications:	4,044
Drug Prices:	Drug price information for TAMBOCOR
DailyMed Link:	TAMBOCOR at DailyMed

Drug patent expirations by year for TAMBOCOR

Recent Clinical Trials for TAMBOCOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wojciech Zareba	Phase 2
Keimyung University Dongsan Medical Center	Phase 4
Chong Kun Dang Pharmaceutical Corp.	Phase 4

See all TAMBOCOR clinical trials

US Patents and Regulatory Information for TAMBOCOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-004	Aug 23, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-001	Oct 31, 1985		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-003	Jun 3, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TAMBOCOR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-001	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-004	Aug 23, 1988	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-002	Oct 31, 1985	⤷ Sign Up	⤷ Sign Up
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-003	Jun 3, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TAMBOCOR

See the table below for patents covering TAMBOCOR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	H01125343	2, 5-BIS (2, 2, 2-TRIFLUOROETHOXY)-ALPHA, APLHA, ALPHA-TRICHLOROACETOPHENONE AND ITS PRODUCTION	⤷ Sign Up
Germany	3010195		⤷ Sign Up
Sweden	463419	ACETOFENONDERIVAT	⤷ Sign Up
Japan	H0251906		⤷ Sign Up
France	2265366		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for TAMBOCOR

Recent Clinical Trials for TAMBOCOR

Make Better Decisions: Try a trial or see plans & pricing